| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00262-011-1057-8 |
| P698 | PubMed publication ID | 21789594 |
| P2093 | author name string | Aldo Pinto | |
| Silvana Morello | |||
| Rosalinda Sorrentino | |||
| P2860 | cites work | Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability | Q22242922 |
| T helper 17 cells promote cytotoxic T cell activation in tumor immunity | Q24646584 | ||
| Human lung cancer cells express functionally active Toll-like receptor 9 | Q24802960 | ||
| Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis | Q28305755 | ||
| Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
| Macrophages, innate immunity and cancer: balance, tolerance, and diversity | Q29614352 | ||
| The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections | Q33322528 | ||
| Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells | Q33590390 | ||
| Toll-like receptor signaling in cell proliferation and survival | Q33598805 | ||
| MyD88-dependent induction of allergic Th2 responses to intranasal antigen. | Q33714813 | ||
| The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. | Q33731751 | ||
| Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance | Q33755300 | ||
| Role of the Innate Immune Response and Tumor Immunity Associated with Simian Virus 40 Large Tumor Antigen | Q34120703 | ||
| Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation | Q34174349 | ||
| Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function | Q34479135 | ||
| Regulating B-cell activation and survival in response to TLR signals | Q34652966 | ||
| Immune escape as a fundamental trait of cancer: focus on IDO. | Q34758085 | ||
| Role of CD83 in the immunomodulation of dendritic cells | Q34982234 | ||
| IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway | Q34989745 | ||
| Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells | Q35575961 | ||
| Toll-like Receptors and Their Signaling Mechanisms | Q35585033 | ||
| The master regulators of allergic inflammation: dendritic cells in Th2 sensitization | Q35589820 | ||
| TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts | Q35894601 | ||
| Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase | Q35925641 | ||
| Regulatory T cells and Toll-like receptors in tumor immunity | Q36392367 | ||
| Pattern recognition receptors and interleukin-8 mediate effects of Gram-positive and Gram-negative bacteria on lung epithelial cell function | Q36736303 | ||
| Development of TLR9 agonists for cancer therapy | Q36809776 | ||
| Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease | Q36834557 | ||
| Isolation, expansion, and characterization of human natural and adaptive regulatory T cells | Q36944532 | ||
| Toll-like receptors expressed in tumor cells: targets for therapy | Q37078915 | ||
| Toll-like receptors in the respiratory system: their roles in inflammation. | Q37123671 | ||
| IDO: a double-edged sword for T(H)1/T(H)2 regulation | Q37281950 | ||
| Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family | Q37316604 | ||
| Toll-like receptors and cancer | Q37340298 | ||
| Toll-like receptors, wound healing, and carcinogenesis | Q37352820 | ||
| Regulatory myeloid suppressor cells in health and disease | Q37373257 | ||
| Macrophages and fibroblasts during inflammation, tissue damage and organ injury | Q37410537 | ||
| Lung vascular endothelial growth factor expression induces local myeloid dendritic cell activation. | Q37428138 | ||
| Mast cells as target in cancer therapy | Q37515897 | ||
| Developmental plasticity of Th17 and Treg cells. | Q37518502 | ||
| Physiology and therapeutics of vascular endothelial growth factor in tumor immunosuppression | Q37581751 | ||
| The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice | Q37728656 | ||
| The role of dendritic and epithelial cells as master regulators of allergic airway inflammation | Q37785230 | ||
| Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer | Q37787437 | ||
| Plasmacytoid dendritic cells prevent cigarette smoke and Chlamydophila pneumoniae-induced Th2 inflammatory responses | Q37854057 | ||
| TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells | Q38339799 | ||
| CpG DNA-mediated immune response in pulmonary endothelial cells | Q38340947 | ||
| Accumulation of Peribronchial Mast Cells in a Mouse Model of Ovalbumin Allergen Induced Chronic Airway Inflammation: Modulation by Immunostimulatory DNA Sequences | Q38348928 | ||
| Failure of mycoplasma lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2. | Q39617839 | ||
| A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth. | Q39637223 | ||
| Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance | Q39726876 | ||
| Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists | Q39784591 | ||
| Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium | Q39997126 | ||
| Inhibiting survivin expression enhances TRAIL-induced tumoricidal activity in human hepatocellular carcinoma via cell cycle arrest | Q40093643 | ||
| Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression | Q40513415 | ||
| Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod. | Q42475595 | ||
| Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen | Q42972592 | ||
| Prostaglandin E2 inhibits IFN-alpha secretion and Th1 costimulation by human plasmacytoid dendritic cells via E-prostanoid 2 and E-prostanoid 4 receptor engagement | Q43216918 | ||
| Inhibitory effects of B cells on antitumor immunity. | Q44423014 | ||
| Endothelial cells augment the suppressive function of CD4+ CD25+ Foxp3+ regulatory T cells: involvement of programmed death-1 and IL-10. | Q46120149 | ||
| Phenotype of dendritic cells generated in the presence of non-small cell lung cancer antigens - preliminary report | Q46164743 | ||
| TLR-dependent activation stimuli associated with Th1 responses confer NK cell stimulatory capacity to mouse dendritic cells. | Q46561897 | ||
| High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance | Q46732718 | ||
| Effect of mast cells on tumor angiogenesis in lung cancer. | Q50510789 | ||
| Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. | Q50751212 | ||
| Division of labor with a workforce of one: challenges in specifying effector and memory T cell fate. | Q51973147 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| toll-like receptor | Q408004 | ||
| P304 | page(s) | 1211-1220 | |
| P577 | publication date | 2011-07-26 | |
| P1433 | published in | Cancer Immunology, Immunotherapy | Q5031409 |
| P1476 | title | Lung cancer and Toll-like receptors | |
| P478 | volume | 60 |
| Q35538723 | Activation of Toll-like receptors signaling in non-small cell lung cancer cell line induced by tumor-associated macrophages |
| Q33577585 | Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination |
| Q33401507 | Bidirectional crosstalk between platelets and monocytes initiated by Toll-like receptor: an important step in the early defense against fungal infections? |
| Q35680341 | Cell Free DNA of Tumor Origin Induces a 'Metastatic' Expression Profile in HT-29 Cancer Cell Line |
| Q38781955 | Differential immunomodulatory activity of tumor cell death induced by cancer therapeutic toll-like receptor ligands |
| Q35458657 | Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide |
| Q58423073 | Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer |
| Q27025290 | Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspects |
| Q66475630 | Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer. |
| Q37208788 | Gram-negative bacteria facilitate tumor outgrowth and metastasis by promoting lipid synthesis in lung cancer patients |
| Q39344117 | HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cells |
| Q28088598 | Harnessing the Microbiome to Enhance Cancer Immunotherapy |
| Q50720651 | High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer. |
| Q36151692 | IFNAR1 is a predictor for overall survival in colorectal cancer and its mRNA expression correlated with IRF7 but not TLR9 |
| Q64229229 | Identification of differentially expressed genes and enriched pathways in lung cancer using bioinformatics analysis |
| Q51371242 | Immune Regulation of Toll-Like Receptor 2 Engagement on CD4+ T Cells in Murine Models of Malignant Pleural Effusion. |
| Q91895917 | Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives |
| Q35832150 | Inherited variation in pattern recognition receptors and cancer: dangerous liaisons? |
| Q33856513 | Integrative approach detected association between genetic variants of microRNA binding sites of TLRs pathway genes and OSCC susceptibility in Chinese Han population |
| Q34310501 | MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway |
| Q41573581 | Molecular Interactions of Autophagy with the Immune System and Cancer |
| Q40119691 | Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like Receptors. |
| Q35911768 | Pharmacological inhibition of caspase-8 limits lung tumour outgrowth. |
| Q47869837 | Recombinant protein rMBP-NAP restricts tumor progression by triggering antitumor immunity in mouse metastatic lung cancer |
| Q47159702 | Role of the inflammasome in chronic obstructive pulmonary disease (COPD). |
| Q49866596 | Roles of toll-like receptors: From inflammation to lung cancer progression |
| Q34733049 | Serum toll-like receptors are potential biomarkers of radiation pneumonia in locally advanced NSCLC. |
| Q35076075 | Systems biology approach to stage-wise characterization of epigenetic genes in lung adenocarcinoma |
| Q37357373 | TLR9 signaling repressed tumor suppressor miR-7 expression through up-regulation of HuR in human lung cancer cells |
| Q39037779 | The mannose-sensitive hemagglutination pilus strain of Pseudomonas aeruginosa shift peritoneal milky spot macrophages towards an M1 phenotype to dampen peritoneal dissemination |
| Q35189391 | The stimulatory activity of plasma in patients with advanced non-small cell lung cancer requires TLR-stimulating nucleic acid immunoglobulin complexes and discriminates responsiveness to chemotherapy |
| Q40978186 | Toll-like receptor 4 signaling inhibits malignant pleural effusion by altering Th1/Th17 responses. |
| Q34415459 | Toll-like receptor-4 signaling in mantle cell lymphoma: effects on tumor growth and immune evasion |
| Q38131726 | Toll-like receptors in urothelial cells--targets for cancer immunotherapy |
| Q34038377 | Ubiquitination by SAG regulates macrophage survival/death and immune response during infection |
Search more.